首页> 外文期刊>Practical Laboratory Medicine >Analytical verification and quality assessment of the Tosoh HLC-723GX HbA1c analyzer
【24h】

Analytical verification and quality assessment of the Tosoh HLC-723GX HbA1c analyzer

机译:Tosoh HLC-723GX HbA 1c 分析仪的分析验证和质量评估

获取原文
           

摘要

Objectives Ion-exchange high-performance liquid chromatography (IE-HPLC) has long been used as a reproducible and versatile analytical tool for HbA 1c measurement. In this study, we performed analytical verification and quality assessment of the recently introduced small IE-HPLC Tosoh HLC-723GX HbA 1c analyzer, and a comparison of results to immunoassay (IA) and capillary electrophoresis (CE). Design and methods The total imprecision of Tosoh HLC-723GX was verified according to CLSI EP15-A2 protocol using commercial control materials (C-QC) and pooled human whole blood samples (HWB). The Sigma metric was used for the evaluation of quality targets. HbA 1c results were compared to automated CE (MiniCap Flex Piercing, Sebia, France) and IA (Tina-quant HbA 1c Gen 2, Cobas Integra 400+, Roche Diagnostics, USA) procedures. Results The total imprecision of Tosoh HLC-723GX-HbA 1c for IFCC(mmol/mol) and NGSP(%) units was: 1.91/1.25% (HbA 1c =31 mmol/mol/5.0%) and 0.51/0.63% (HbA 1c =84 mmol/mol/9.8%) for C-QC, and 0.39/0.2% (HbA 1c =47 mmol/mol/6.5%) and 0.77/0.46% (HbA 1c =94 mmol/mol/10.8%) in HWB samples, respectively. Bland-Altman analysis did not reveal any deviation of the results between Tosoh HLC-723GX and CE: mean difference 0.0% (95%CI: ?0.02927 to 0.02653%), while the mean HbA 1c difference against IA was ?0.07% (95%CI: ?0.1039 to ?0.02765). At the selected HbA 1c clinical decision level (48 mmol/mol/6,5%), six sigma analysis gave σ value of 3.91, within a desirable classification of performance. Conclusion The analytical performance of the Tosoh HLC-723GX complies with the rigorous quality criteria for clinical use of HbA 1c , with the results comparable to the CE procedure. Tosoh HLC-723GX provides a plausible analytical choice for reliable HbA 1c measurement in low-volume laboratories. Highlights ? Compliance to the rigorous quality targets is necessary for the reliable clinical use of HbA 1c . ? A small, fully automated benchtop HbA 1c analyzer (Tosoh HLC-723GX) was evaluated. ? Tosoh HLC-723GX anaylzer met the six sigma-based quality targets. ? Low-volume laboratories could provide clinically reliable HbA1c results by the Tosoh HLC-723GX analyzer.
机译:目的离子交换高效液相色谱(IE-HPLC)长期以来一直用作HbA 1c测量的可重现和通用分析工具。在这项研究中,我们对最近推出的小型IE-HPLC Tosoh HLC-723GX HbA 1c分析仪进行了分析验证和质量评估,并将结果与​​免疫分析(IA)和毛细管电泳(CE)进行了比较。设计和方法根据CLSI EP15-A2协议,使用商业对照材料(C-QC)和合并的人类全血样品(HWB),验证了Tosoh HLC-723GX的总不精确度。 Sigma度量标准用于评估质量目标。将HbA 1c结果与自动CE(MiniCap Flex Piercing,法国Sebia)和IA(Tina-quant HbA 1c Gen 2,Cobas Integra 400+,美国Roche Diagnostics,美国)程序进行了比较。结果Tosoh HLC-723GX-HbA 1c对于IFCC(mmol / mol)和NGSP(%)单位的总不准确度为:1.91 / 1.25%(HbA 1c = 31 mmol / mol / 5.0%)和0.51 / 0.63%(HbA C-QC的1c = 84 mmol / mol / 9.8%,H-A中的0.39 / 0.2%(HbA 1c = 47 mmol / mol / 6.5%)和0.77 / 0.46%(HbA 1c = 94 mmol / mol / 10.8%) HWB样本分别。 Bland-Altman分析并未显示Tosoh HLC-723GX与CE之间的结果有任何偏差:平均差异为0.0%(95%CI:0.02927至0.02653%),而HbA 1c与IA的平均差异为0.07%(95) %CI:〜0.1039至〜0.02765)。在选定的HbA 1c临床决策水平(48 mmol / mol / 6,5%)下,六个sigma分析得出的σ值为3.91,处于理想的性能分类内。结论Tosoh HLC-723GX的分析性能符合HbA 1c临床使用的严格质量标准,其结果可与CE程序相媲美。 Tosoh HLC-723GX为小容量实验室中的可靠HbA 1c测量提供了合理的分析选择。强调 ?符合严格的质量目标对于HbA 1c的可靠临床应用是必要的。 ?对小型,全自动台式HbA 1c分析仪(Tosoh HLC-723GX)进行了评估。 ? Tosoh HLC-723GX分析仪达到了六个基于sigma的质量目标。 ?小体积的实验室可以通过Tosoh HLC-723GX分析仪提供临床上可靠的HbA1c结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号